Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors

NCT05886868 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: BL0020

Sponsor

Shanghai Best-Link Bioscience, LLC